Research articleShortage of influenza vaccine in 2000–2001: Did it change patient beliefs?☆
Introduction
D uring the influenza vaccination season of 2000–2001, there was an unprecedented, widespread, and highly publicized delay in distribution of influenza vaccine. By the end of October 2000, only 26.6 million doses (38% of the total) had been distributed, compared with 75.8 million doses (99% of the total) by the end of October 1999.1 This delay was due to difficulties encountered by some manufacturers in growing the H3N2 strain, regulatory issues related to the Food and Drug Administration’s good manufacturing practices, and the decision by one manufacturer to permanently cease influenza vaccine production.1 Depending on their vaccine source(s), providers may have received their supplies up to 3 months later than usual, in reduced amounts, and frequently at higher cost than in previous years. Younger healthy people were asked to delay getting the influenza vaccine to ensure that older and high-risk individuals had the first opportunity to receive the vaccine while supplies were limited.2 However, distribution was uneven: providers serving primarily older and high-risk populations frequently did not receive vaccine, while employers and others serving low-risk populations did.1 These distribution patterns may have changed how influenza disease and vaccine were perceived by individuals who should have received vaccine first.
This study examined changes in patient perceptions of the influenza vaccine during the 2000–2001 influenza season in a population that was surveyed the previous year.
Section snippets
Subjects
Following the 1999–2000 influenza season, a telephone survey of older patients was conducted. Participants were selected using a two-stage stratified random cluster sample3, 4, 5 regarding attitudes and beliefs about influenza vaccine and disease. For the present study, all patients were selected from the previous study sample and from four inner-city practices (three of which received influenza vaccine on time and one that received it late, in December) as well as from a random sample of
Response rate
Among the 387 sampled patients, 25 were found to be ineligible, 43 refused or could not be contacted, and 319 agreed to participate in the second interview—for a response rate of 82% (319/387).
Demographics
Demographic characteristics of the study sample are shown in Table 1. This population was predominantly female, of white race, widowed, of lower educational level, and of low to moderate household income. Differences occurred among the practice location/timing groups for age (p<0.01); gender (p<0.01);
Discussion
What was the impact of the delay in influenza vaccine distribution for 2000–2001? We offer three consequences that were modest in degree: (1) decreased vaccination rates; (2) increased patient concerns about vaccine safety; and (3) increased patient concerns about vaccine efficacy. The production difficulties encountered in 2000 resulted in a significant delay in distribution and reduction in vaccine supplies. Of the 70.4 million doses made in 2000 (down from 77.9 million doses in 19991), 7.5
Conclusions
The ever-present possibility of pandemic influenza and the withdrawal of two manufacturers from the inactivated influenza vaccine market highlight the fact that shortages could occur in the future. Small increases in concerns about vaccines during a vaccine shortage, even among adults with good access to vaccine supplies, suggest the need for clear messages regarding vaccine safety and efficacy along with availability reports.
Acknowledgements
This project was approved by the Institutional Review Board of the University of Pittsburgh. This publication/project was funded by an Association of Teachers of Preventive Medicine (ATPM)–Centers for Disease Control and Prevention (CDC) cooperative agreement (TS-0550-16/16). The contents are the responsibility of the authors and do not necessarily reflect the official views of the CDC or ATPM. We are grateful to Richard Bruehlman, MD, for assistance with data collection and project design.
This
References (24)
- et al.
Patient acceptance of influenza vaccination
Am J Med
(1991) - et al.
Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients
Am J Prev Med
(1999) - et al.
Estimation of outpatient risk characteristics and influenza vaccination statusvalidation of a self-administered questionnaire
Am J Prev Med
(1991) - et al.
How the delayed distribution of influenza vaccine created shortages in 2000 and 2001
Proc Annu Symp Comput Appl Med
(2002) - Centers for Disease Control and Prevention. Delayed supply of influenza vaccine and adjunct ACIP influenza vaccine...
- et al.
A comprehensive investigation of barriers to adult immunizationa methods paper
J Fam Pract
(2001) - et al.
Knowledge and beliefs about influenza, pneumococcal disease, and immunizations among the elderly
J Am Geriatr Soc
(2002) - Zimmerman RK, Santibanez TA, Janosky JE, et al. What affects influenza vaccination rates among older patients? An...
Predicting and understanding influenza vaccination behavior. Alternatives to the health belief model
Med Care
(1986)- et al.
Cross-cultural model testingtoward a solution of the etic-emic dilemma
Int J Psychol
(1976)
A comparison of the Fishbein and Ajzen and the Triandis attitudinal models for the prediction of exercise intention and behavior
J Behav Med
Habit and behavioral intentions as predictors of social behavior
J Soc Psychol
Cited by (16)
Racial/ethnic disparities in the use of preventive services among the elderly
2005, American Journal of Preventive MedicineParental perspectives on influenza immunization of children aged 6 to 23 months
2005, American Journal of Preventive MedicineImpact of vaccine shortages on immunization programs and providers
2004, American Journal of Preventive MedicineEffects of the year 2000 influenza vaccine delay on elderly patients' attitudes and behaviors
2003, Preventive MedicineWhere high-risk adults receive influenza vaccine during a shortage [1]
2007, Archives of Internal Medicine
- ☆
The full text of this article is available via AJPM Online at www.ajpm-online.net.